The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Tumor targeted delivery of umbelliferone via a smart mesoporous silica nanoparticles controlled-release drug delivery system for increased anticancer efficiency
Abstract
Herein, a mesoporous silica nanoparticle (MSN) based biocompatible, targeted and controlled drug delivery system has been synthesized for tumor tissue-specific drug delivery. Umbelliferone, a natural coumarin derivative was loaded into the pores of MSN and capped with pH-sensitive poly acrylic acid (PAA). For targeted delivery of umbelliferone in tumor tissue, folic acid (FA) was grafted onto the surface of drug-loaded and PAA-coated MSN. The successful construction of the nanohybrid (Umbe@MSN-PAA-FA) was confirmed by performing a series of characterization. The synthesized pH-responsive nanohybrid showed diameter of around 50 nm with overall negative surface charge and drug loading content of 12.56%. In vitro study showed that the nanohybrid caused significant cytotoxicity through the induction of both oxidative stress as well as mitochondrial damage in folate receptor over-expressed in human breast cancer cell, MCF-7 compared with free umbelliferone. In vivo study also exhibited that the nanohybrid effectively reduced tumor growth in tumor-bearing mice compared with free umbelliferone due to the enlarged bioavailability of the drug in tumor tissue. Besides, the nanohybrid did not exhibit any significant sign of systemic toxicity in other vital organs. Together, the study denoted that PAA and FA functionalized MSN controlled-drug delivery system could assist to increase the anticancer potential of umbelliferone.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Various oral nano-based approaches and targeted drug delivery systems have been developed recently, as a result of the ability of nanoparticles to control the release of the encapsulant, drug targeting and reduce the number of dosages administered.”
From Current Advances in Chitosan Nanoparticles Based Oral Drug Delivery for Colorectal Cancer Treatment (2022) · cites this paper as [12]
In the citing paper
“Furthermore, since nanoparticles allow for continuous or controlled release, the physical encapsulation of anticancer drugs improves their pharmacokinetic properties while reducing the number of dosages administered.”
From Current Advances in Chitosan Nanoparticles Based Oral Drug Delivery for Colorectal Cancer Treatment (2022) · cites this paper as [12]
In the citing paper
“This controlled release can circumvent multiple drug resistance since the cells actively ingest bigger amounts of the drug intracellularly.12–14”
From Current Advances in Chitosan Nanoparticles Based Oral Drug Delivery for Colorectal Cancer Treatment (2022) · cites this paper as [12]
Citations
Cites
Polymeric systems for controlled drug release
Uhrich, K. E., Cannizzaro, S. M., Langer, R. S., & Shakesheff, K. M. (1999) · Chemical Reviews · doi:10.1021/cr940351u · Cited by 2,633
Flagged first, then by citations
Research works printed but not linked: 41
- Li, 2018, Curcumin-loaded redox-responsive mesoporous silica nanoparticles for targeted breast cancer therapy, Artificial cells, nanomedicine, and biotechnology, 46, 921, 10.1080/21691401.2018.1473412 · DOI
- Gupta, 2015, A review of breast cancer awareness among women in India: cancer literate or awareness deficit?, Eur. J. Cancer, 51, 2058, 10.1016/j.ejca.2015.07.008 · DOI
- Sawada, 2017, Risk and preventive factors for prostate cancer in Japan: the Japan Public Health Center-based prospective (JPHC) study, Journal of Epidemiology, 27, 2, 10.1016/j.je.2016.09.001 · DOI
- Sullivan, 2008, Minimally invasive protein delivery with rapidly dissolving polymer microneedles, Adv. Mater., 20, 933, 10.1002/adma.200701205 · DOI
- Chowdhury, 2016, Taurine protects cisplatin induced cardiotoxicity by modulating inflammatory and endoplasmic reticulum stress responses, Biofactors, 42, 647, 10.1002/biof.1301 · DOI
- Sompar, 2015, Protective effects of tetrahydrocurcumin and curcumin against doxorubicin and cadmium-induced cytotoxicity in Chang liver cells, Trop. J. Pharm. Res., 14, 769, 10.4314/tjpr.v14i5.4 · DOI
- Kumar, 2017, Fabrication, optimization, and characterization of umbelliferone β-D-galactopyranoside-loaded PLGA nanoparticles in treatment of hepatocellular carcinoma: in vitro and in vivo studies, Int. J. Nanomedicine, 12, 6747, 10.2147/IJN.S136629 · DOI
- Engel, 2011, Proliferative effects of five traditional Nigerian medicinal plant extracts on human breast and bone cancer cell lines, J. Ethnopharmacol., 137, 1003, 10.1016/j.jep.2011.07.023 · DOI
- Anwar, 2015, Umbelliferone β-d-galactopyranoside inhibits chemically induced renal carcinogenesis via alteration of oxidative stress, hyperproliferation and inflammation: possible role of NF-κB, Toxicology Research, 4, 1308, 10.1039/C5TX00146C · DOI
- Yu, 2015, Umbelliferone exhibits anticancer activity via the induction of apoptosis and cell cycle arrest in HepG2 hepatocellular carcinoma cells, Mol. Med. Rep., 12, 3869, 10.3892/mmr.2015.3797 · DOI
- Oussoren, 2001, Liposomes to target the lymphatics by subcutaneous administration, Adv. Drug Deliv. Rev., 50, 143, 10.1016/S0169-409X(01)00154-5 · DOI
- Tang, 2013, Nonporous silica nanoparticles for nanomedicine application, Nano Today, 8, 290, 10.1016/j.nantod.2013.04.007 · DOI
- Wang, 2013, Particle-size-dependent toxicity and immunogenic activity of mesoporous silica-based adjuvants for tumor immunotherapy, Acta Biomater., 9, 7480, 10.1016/j.actbio.2013.03.031 · DOI
- Watermann, 2017, Mesoporous silica nanoparticles as drug delivery vehicles in cancer, Nanomaterials, 7, 189, 10.3390/nano7070189 · DOI
- AbouAitah, 2016, Mesoporous silica materials in drug delivery system: pH/glutathione-responsive release of poorly water-soluble pro-drug quercetin from two and three-dimensional pore-structure nanoparticles, J Nanomed Nanotechnol, 7
- Natarajan, 2014, Mesoporous silica nanoparticles: importance of surface modifications and its role in drug delivery, RSC Adv., 4, 14328, 10.1039/c4ra00781f · DOI
- Li, 2019, Tumor microenvironment responsive shape-reversal self-targeting virus-inspired nanodrug for imaging-guided near-infrared-II photothermal chemotherapy, ACS Nano, 13, 12912, 10.1021/acsnano.9b05425 · DOI
- Liu, 2015, Enzyme responsive mesoporous silica nanoparticles for targeted tumor therapy in vitro and in vivo, Nanoscale, 7, 3614, 10.1039/C5NR00072F · DOI
- Weinstein, 2003, Null association between prostate cancer and serum folate, vitamin B6, vitamin B12, and homocysteine, Cancer Epidemiology and Prevention Biomarkers, 12, 1271
- Lu, 2002, Folate-mediated delivery of macromolecular anticancer therapeutic agents, Adv. Drug Deliv. Rev., 54, 675, 10.1016/S0169-409X(02)00042-X · DOI
- Li, 2020, Tumor microenvironment-activated self-recognizing nanodrug through directly tailored assembly of small-molecules for targeted synergistic chemotherapy, J. Control. Release, 321, 222, 10.1016/j.jconrel.2020.02.025 · DOI
- Li, 2017, Chemotherapeutic drug-photothermal agent co-self-assembling nanoparticles for near-infrared fluorescence and photoacoustic dual-modal imaging-guided chemo-photothermal synergistic therapy, J. Control. Release, 258, 95, 10.1016/j.jconrel.2017.05.011 · DOI
- Xiao, 2016, pH-triggered sustained release of arsenic trioxide by polyacrylic acid capped mesoporous silica nanoparticles for solid tumor treatment in vitro and in vivo, J. Biomater. Appl., 31, 23, 10.1177/0885328216637211 · DOI
- Peng, 2013, A pH-responsive nano-carrier with mesoporous silica nanoparticles cores and poly (acrylic acid) shell-layers: fabrication, characterization and properties for controlled release of salidroside, Int. J. Pharm., 446, 153, 10.1016/j.ijpharm.2013.01.071 · DOI
- Yuan, 2011, Preparation of pH-responsive mesoporous silica nanoparticles and their application in controlled drug delivery, J. Phys. Chem. C, 115, 9926, 10.1021/jp201053d · DOI
- Saroj, 2018, Tailor-made pH-sensitive polyacrylic acid functionalized mesoporous silica nanoparticles for efficient and controlled delivery of anti-cancer drug Etoposide, Drug Dev. Ind. Pharm., 44, 1198, 10.1080/03639045.2018.1438467 · DOI
- Das, 2016, Efficient delivery of C/EBP beta gene into human mesenchymal stem cells via polyethylenimine-coated gold nanoparticles enhances adipogenic differentiation, Sci. Rep., 6
- Das, 2015, Hexavalent chromium induces apoptosis in human liver (HepG2) cells via redox imbalance, Toxicol. Rep., 2, 600, 10.1016/j.toxrep.2015.03.013 · DOI
- Tsai, 2012, ERK-modulated intrinsic signaling and G2/M phase arrest contribute to the induction of apoptotic death by allyl isothiocyanate in MDA-MB-468 human breast adenocarcinoma cells, Int. J. Oncol., 41, 2065, 10.3892/ijo.2012.1640 · DOI
- Sinha, 2015, Morin protects gastric mucosa from nonsteroidal anti-inflammatory drug, indomethacin induced inflammatory damage and apoptosis by modulating NF-κB pathway, Biochimica et Biophysica Acta (BBA)-General Subjects, 1850, 769, 10.1016/j.bbagen.2015.01.008 · DOI
- Bhattacharya, 2015, PEGylated-thymoquinone-nanoparticle mediated retardation of breast cancer cell migration by deregulation of cytoskeletal actin polymerization through miR-34a, Biomaterials, 51, 91, 10.1016/j.biomaterials.2015.01.007 · DOI
- Molnar, 2017, Comparison of various techniques for the extraction of umbelliferone and herniarin in Matricaria chamomilla processing fractions, Chemistry Central Journal, 11, 78, 10.1186/s13065-017-0308-y · DOI
- Fischer, 2008, Hematoxylin and eosin staining of tissue and cell sections, Cold Spring Harb Protoc, 2008, 10.1101/pdb.prot4986 · DOI
- Parasuraman, 2010, Blood sample collection in small laboratory animals, J. Pharmacol. Pharmacother., 1, 87, 10.4103/0976-500X.72350 · DOI
- Ahir, 2016, Tailored-CuO-nanowire decorated with folic acid mediated coupling of the mitochondrial-ROS generation and miR425-PTEN axis in furnishing potent anti-cancer activity in human triple negative breast carcinoma cells, Biomaterials, 76, 115, 10.1016/j.biomaterials.2015.10.044 · DOI
- Pecora, 2000, Dynamic light scattering measurement of nanometer particles in liquids, J. Nanopart. Res., 2, 123, 10.1023/A:1010067107182 · DOI
- Rameli, 2018, Synthesis and characterization of mesoporous silica nanoparticles using ionic liquids as a template, Journal of Physics: Conference Series, IOP Publishing, 012068
- Lacatusu, 2013, Antioxidant activity of solid lipid nanoparticles loaded with umbelliferone, Soft Materials, 11, 75, 10.1080/1539445X.2011.582914 · DOI
- Sarkar, 2016, Targeted delivery of quercetin loaded mesoporous silica nanoparticles to the breast cancer cells, Biochimica et Biophysica Acta (BBA)-General Subjects, 1860, 2065, 10.1016/j.bbagen.2016.07.001 · DOI
- Nizomov, 2007, Electronic structure and spectral fluorescence properties of umbelliferone and herniarin, J. Appl. Spectrosc., 74, 626, 10.1007/s10812-007-0102-z · DOI
- Sadhukhan, 2015, Targeting oxidative stress: a novel approach in mitigating cancer, Biochem Anal Biochem, 4
Cited by
Sorted by citations
Sun, W., & Shahrajabian, M. H. (2023) · Molecules · doi:10.3390/molecules28041845 · Cited by 806
Preparation and application of pH-responsive drug delivery systems
Ding, H., Tan, P., Fu, S., Tian, X., Zhang, H., Ma, X., Gu, Z., & Luo, K. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.05.056 · Cited by 645
Current Advances in Chitosan Nanoparticles Based Oral Drug Delivery for Colorectal Cancer Treatment
Choukaife, H., Seyam, S., Alallam, B., Doolaanea, A. A., & Alfatama, M. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s375229 · Cited by 127
Metadata
- Authors
- Kundu, M., Chatterjee, S., Ghosh, N., Manna, P., Das, J., & Sil, P. C.
- Venue
- Materials Science and Engineering: C
- Publisher
- Elsevier BV
- Published
- 2020-11
- Volume
- 116
- Pages
- 111239
- ISSN
- 0928-4931
- Cited by
- 89
- References
- 1
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review